Abnormal NF-κB activation was identified in cancer cells, which promoted invasion and migration by increasing expressions of MMPs and vascular endothelial growth factor (VEGF) in prostate cancer PC-3 cells [41]. The gene discussed is NFKB1; the disease is prostate carcinoma.